Security National Bank of Sioux City Iowa IA Boosts Stake in Laboratory Corporation of America Holdings (LH)

Security National Bank of Sioux City Iowa IA grew its holdings in shares of Laboratory Corporation of America Holdings (NYSE:LH) by 0.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,871 shares of the medical research company’s stock after purchasing an additional 2 shares during the period. Laboratory Corporation of America Holdings makes up 2.1% of Security National Bank of Sioux City Iowa IA’s portfolio, making the stock its 8th biggest holding. Security National Bank of Sioux City Iowa IA’s holdings in Laboratory Corporation of America Holdings were worth $2,138,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Acrospire Investment Management LLC boosted its position in shares of Laboratory Corporation of America Holdings by 16.5% during the 2nd quarter. Acrospire Investment Management LLC now owns 705 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 100 shares in the last quarter. Sun Life Financial INC boosted its position in shares of Laboratory Corporation of America Holdings by 9,200.0% during the 2nd quarter. Sun Life Financial INC now owns 744 shares of the medical research company’s stock valued at $115,000 after purchasing an additional 736 shares in the last quarter. Parallel Advisors LLC boosted its position in shares of Laboratory Corporation of America Holdings by 377.7% during the 1st quarter. Parallel Advisors LLC now owns 1,261 shares of the medical research company’s stock valued at $177,000 after purchasing an additional 997 shares in the last quarter. IFP Advisors Inc boosted its position in shares of Laboratory Corporation of America Holdings by 83.9% during the 2nd quarter. IFP Advisors Inc now owns 1,146 shares of the medical research company’s stock valued at $177,000 after purchasing an additional 523 shares in the last quarter. Finally, Hourglass Capital LLC bought a new position in shares of Laboratory Corporation of America Holdings during the 2nd quarter valued at about $200,000. Institutional investors own 93.19% of the company’s stock.

In related news, CEO David P. King sold 132,713 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $157.06, for a total value of $20,843,903.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO David P. King sold 44,687 shares of the business’s stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $156.86, for a total value of $7,009,602.82. Following the completion of the transaction, the chief executive officer now owns 258,753 shares of the company’s stock, valued at $40,587,995.58. The disclosure for this sale can be found here. Insiders sold a total of 222,968 shares of company stock valued at $34,980,922 over the last quarter. 0.90% of the stock is owned by insiders.

Laboratory Corporation of America Holdings (LH) traded up 0.18% during mid-day trading on Tuesday, hitting $149.54. 157,650 shares of the company traded hands. The company has a market capitalization of $15.22 billion, a price-to-earnings ratio of 20.94 and a beta of 0.92. The company’s 50-day moving average price is $153.90 and its 200 day moving average price is $148.74. Laboratory Corporation of America Holdings has a one year low of $119.51 and a one year high of $164.22.

Laboratory Corporation of America Holdings (NYSE:LH) last announced its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.47 EPS for the quarter, beating analysts’ consensus estimates of $2.40 by $0.07. The company had revenue of $2.50 billion during the quarter, compared to analysts’ expectations of $2.47 billion. Laboratory Corporation of America Holdings had a return on equity of 16.85% and a net margin of 7.57%. Laboratory Corporation of America Holdings’s revenue was up 4.9% on a year-over-year basis. During the same period in the prior year, the business posted $2.36 EPS. On average, analysts anticipate that Laboratory Corporation of America Holdings will post $9.53 earnings per share for the current fiscal year.

LH has been the subject of several recent analyst reports. BidaskClub upgraded shares of Laboratory Corporation of America Holdings from a “buy” rating to a “strong-buy” rating in a report on Wednesday, June 28th. Morgan Stanley raised their target price on shares of Laboratory Corporation of America Holdings from $154.00 to $166.00 and gave the stock an “overweight” rating in a report on Thursday, August 10th. Jefferies Group LLC reiterated a “hold” rating and issued a $170.00 target price (up from $157.00) on shares of Laboratory Corporation of America Holdings in a report on Wednesday, September 13th. Canaccord Genuity reiterated a “buy” rating and issued a $180.00 target price (up from $175.00) on shares of Laboratory Corporation of America Holdings in a report on Monday, September 11th. Finally, Craig Hallum reiterated a “buy” rating and issued a $179.00 target price (up from $157.00) on shares of Laboratory Corporation of America Holdings in a report on Thursday, July 27th. Six investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $165.55.

WARNING: “Security National Bank of Sioux City Iowa IA Boosts Stake in Laboratory Corporation of America Holdings (LH)” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at https://www.com-unik.info/2017/10/10/security-national-bank-of-sioux-city-iowa-ia-boosts-stake-in-laboratory-corporation-of-america-holdings-lh.html.

About Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corporation of America Holdings (NYSE:LH).

Institutional Ownership by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)

What are top analysts saying about Laboratory Corporation of America Holdings? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Laboratory Corporation of America Holdings and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit